Sign Up to like & get
recommendations!
1
Published in 2018 at "AIDS"
DOI: 10.1097/qad.0000000000001823
Abstract: Together with the increase in life expectancy of HIVinfected individuals with antiretroviral therapy (ART), morbidity and mortality from liver disease has sharply increased in individuals coinfected with hepatitis C or B and exhibit advanced liver…
read more here.
Keywords:
hepatocellular carcinoma;
carcinoma;
treatment cirrhotic;
risk hepatocellular ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Drug and Alcohol Review"
DOI: 10.1111/dar.12883
Abstract: INTRODUCTION AND AIMS Direct acting antiviral (DAA) treatment can reduce hepatitis C virus (HCV) infection incidence and mortality, although large scale uptake of these treatments is necessary to achieve those reductions. Targeting people who inject…
read more here.
Keywords:
treatment;
direct acting;
acting antiviral;
hepatitis virus ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2021.27.7.873
Abstract: BACKGROUND: There is evidence that barriers exist for the initiation of direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) for those with substance use disorders (SUDs). However, real world clinical evidence of DAA treatment…
read more here.
Keywords:
infected patients;
treatment;
daa treatment;
treatment initiation ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Pathogens"
DOI: 10.3390/pathogens11080860
Abstract: (1) Background: direct-acting antivirals (DAA) are the current standard of care for chronic hepatitis C. Oncologic patients remain among the most difficult-to-treat subgroups of hepatitis C virus (HCV)-infected patients due to their clinical frailty and…
read more here.
Keywords:
chronic hepatitis;
safety efficacy;
daa treatment;
hepatitis ... See more keywords